Coherus Oncology (CHRS) Net Margin (2013 - 2026)
Coherus Oncology (CHRS) recorded Net Margin of -144.20% in Q2 2026, down 3048.11 percentage points from 2903.91% a year earlier but up 167.15 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Net Margin (2013 - 2026) Analysis & Trends
On a TTM basis, Coherus Oncology's Net Margin came in at -259.41% as of Jun 30, 2026, down 827.56 percentage points year-over-year; for FY2025, it was 398.43%, up 290.40 percentage points from FY2024.
- Annual Net Margin has increased for three straight years, with a five-year change of +370.63 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 108.03% in FY2024 (+200.50 pp), -92.48% in FY2023 (+45.77 pp), -138.24% in FY2022 (-50.33 pp) and -87.92% in FY2021 (-115.71 pp).
- Quarterly Net Margin has ranged from -744.43% in Q1 2025 to 4457.32% in Q1 2024 over the past five years.
- On a year-over-year basis, Net Margin rose in three of the last eight quarters, with an average year-over-year change of -656.19 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 4690.79 percentage points in Q1 2024, against a drop of 5201.75 percentage points in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -311.35% (Q1 2026), -295.29% (Q4 2025) and -307.07% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.28 Bn | 1,194.89 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 653.62 Bn | 573.48 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 509.01 Bn | 477.02 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.31 Bn | 325.26 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 312.49 Bn | 285.73 Bn | - | - |
| 6 | Astrazeneca | 285.84 Bn | 259.73 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 248.19 Bn | 199.85 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.17 Bn | 183.27 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 166.64 Bn | 114.00 Bn | 12.56 Bn | 19.55% |
| 10 | Coherus Oncology | 116.82 Mn | -519.32 Mn | 10.07 Mn | -144.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -144.20% |
| Mar 31, 2026 | -311.35% |
| Dec 31, 2025 | -295.29% |
| Sep 30, 2025 | -307.07% |
| Jun 30, 2025 | 2,903.91% |
| Mar 31, 2025 | -744.43% |
| Dec 31, 2024 | -655.58% |
| Sep 30, 2024 | -177.64% |
| Jun 30, 2024 | -125.50% |
| Mar 31, 2024 | 4,457.32% |
| Dec 31, 2023 | -87.03% |
| Sep 30, 2023 | -53.16% |
| Jun 30, 2023 | -73.01% |
| Mar 31, 2023 | -233.47% |
| Dec 31, 2022 | -129.81% |
| Sep 30, 2022 | -190.76% |
| Jun 30, 2022 | -83.37% |
| Mar 31, 2022 | -159.83% |
| Dec 31, 2021 | -62.34% |
| Sep 30, 2021 | -46.70% |
API Access
Coherus Oncology Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();